OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 Would you advise parents not to have their children vaccinated
  2. 2 How do vaccinated children compare to unvaccinated children on all-cause mortality, serious adverse events, or long-term health.

Answered on this page ↓

How do vaccinated children compare to unvaccinated children on all-cause mortality, serious adverse events, or long-term health.

Sep 2, 2026 · 9 sources used · OpenNeedle synthesis
The short version: the evidence you were given answers a different question.

None of the studies in this retrieval compares vaccinated children to unvaccinated children on all-cause mortality, serious adverse events, or long-term health. The closest one is a 2000 study from Guinea-Bissau [4] that found children who received diphtheria-tetanus-pertussis (DTP) vaccine had nearly double the mortality (mortality ratio 1.84, confidence interval 1.10 to 3.10) compared to unvaccinated children, while BCG and measles vaccines were associated with lower mortality. That study was observational and from a low-income country with high background disease rates. The remainder of the evidence covers vaccine coverage rates in El Salvador [1], cost savings in the US [3], the COVID-19 pandemic's effect on Swiss vaccination timeliness [5], and a review of COVID-19 vaccine myocarditis [9]. Not one study tracks a US or European cohort of vaccinated versus unvaccinated children from infancy through childhood counting all-cause death or serious harm. The most informative study design was never run. The burden of proof has not been met.

My call: the evidence provided does not show whether vaccinated children do better or worse than unvaccinated children on the outcomes that matter most. The data to answer this question does not exist in this retrieval. Confidence: high that the retrieval lacks it, not clear what the answer is.

Keep digging

Sources used 9

  1. Routine childhood vaccination programme coverage, El Salvador, 2011—In search of timeliness Vaccine (2014) Thin

    This study assessed vaccination coverage and timeliness for routine childhood vaccinations in El Salvador, revealing high overall coverage but significant delays in timely vaccination, particularly for the rotavirus vaccine.

    DOI: 10.1016/j.vaccine.2013.11.072
  2. Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood Vaccines Pediatric Infectious Disease Journal (2009) Thin

    This study evaluates the safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines, comparing it to the licensed 7-valent pneumococcal conjugate vaccine (7…

    DOI: 10.1097/INF.0b013e318199f62d
  3. Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001 Archives of Pediatrics & Adolescent Medicine (2005) Thin

    A comprehensive decision-analytic evaluation showing that the 7-vaccine routine childhood immunization schedule in the United States (2001) yields substantial net savings and high benefit-cost ratios compared with no vaccination, across direct and societal perspectives.

    DOI: 10.1001/archpedi.159.12.1136
  4. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa Commentary: an unexpected finding that needs confirmation or rejection BMJ (2000) Thin

    This study investigates the association between routine childhood vaccinations and infant survival in rural Guinea-Bissau, revealing that BCG and measles vaccines are linked to lower mortality, while diphtheria, tetanus, and pertussis vaccines are associated with higher mortalit…

    DOI: 10.1136/bmj.321.7274.1435
  5. Impact of the COVID-19 pandemic on routine childhood immunisation coverage and timeliness in Switzerland: a retrospective analysis using data from the Swiss National Vaccination Coverage Survey, 2019–2023 Swiss Medical Weekly (2025) Thin

    A nationwide retrospective analysis of Swiss SNVCS data (2019–2023) finds that the COVID-19 pandemic largely preserved routine childhood vaccination uptake in children under 35 months in Switzerland, with only small, non-significant differences in timely vaccination for DTP and …

    DOI: 10.57187/s.4525
  6. Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua New Guinea International Journal of Epidemiology (2004) Thin

    This study investigates the impact of routine childhood immunizations on mortality rates in children from Tari, Papua New Guinea, revealing significant effects of various vaccines on survival.

    DOI: 10.1093/ije/dyh262
  7. Randomised cluster trial to support informed parental decision-making for the MMR vaccine BMC Public Health (2011) Thin

    A cluster-randomised UK trial evaluated a parent-centred, multi-component decision support intervention (MMR information leaflet plus a two-hour parent meeting) vs leaflet alone, finding both reduced decisional conflict and that the parent meeting increased actual vaccination up…

    DOI: 10.1186/1471-2458-11-475
  8. Histopathological Impact of Long COVID on Organ Tissues Study the long-term tissue-level effects of post-acute COVID syndrome. International Journal For Multidisciplinary Research (2025) Thin

    This article synthesizes multi-organ evidence from imaging, autopsy, and cohort studies to argue that SARS-CoV-2 infection can cause widespread organ damage and multisystem involvement beyond symptomatic Long COVID, outlining brain, vascular/endothelial, endocrine, immune, and s…

    DOI: 10.36948/ijfmr.2025.v07i04.50712
  9. Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination Open Heart (2022) narrative review Strong

    This narrative review summarizes evidence that COVID-19 and mRNA COVID-19 vaccination can cause rare myocarditis, most common in younger males after second dose, with favourable short-term course and benefit-risk favouring vaccination.

    DOI: 10.1136/openhrt-2021-001957

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question